Skip to content

Medtronic MDT Ratios & Valuation

FY'26FY'25FY'24FY'23
Profitability
Gross margin260.7%-0.1pp260.8%-1.1pp261.9%-5.0pp266.9%-2.9pp
Operating margin70.6%+3.8pp66.8%-1.9pp68.6%-5.5pp74.1%+6.6pp
Net margin53.5%+1.8pp51.8%+3.1pp48.7%-7.4pp56%-2.4pp
EBITDA margin104.7%+5.2pp99.4%-2.7pp102.1%-6.9pp109%+7.4pp
Free cash flow margin60.7%-3.7pp64.4%+6.3pp58.1%-4.2pp62.3%-11.1pp
Returns
Return on equity38.8%+4.3pp34.4%+4.1pp30.3%-3.1pp33.4%-2.7pp
Return on assets20.7%+1.7pp19%+1.9pp17.1%-1.8pp18.9%-1.0pp
Return on invested capital27%+2.8pp24.3%+2.7pp21.6%-2.3pp23.9%-1.7pp
Efficiency
Asset turnover1.5×+0.1×1.5×+0.1×1.4×+0.1×1.3×0.0×
Inventory turnover8.5×+0.2×8.3×+0.1×8.3×-0.4×8.6×-0.7×
Liquidity
Current ratio9.1×+1.4×7.7×-1.3×+1.6×7.5×-2.8×
Quick ratio6.8×+0.9×5.8×-0.9×6.7×+0.9×5.8×-2.5×
Cash ratio0.5×0.0×0.5×0.0×0.6×-0.4×-0.5×
Leverage
Debt-to-equity2.4×0.0×2.3×+0.3×-0.1×2.1×-0.1×
Debt-to-assets1.3×0.0×1.2×+0.1×1.1×0.0×1.2×0.0×
Net debt / EBITDA11.9×-1.1×13×+1.2×11.7×+0.7×11.1×-1.0×
Interest coverage34.6×+5.0×29.6×-2.9×32.4×-6.4×38.9×+3.4×
Per Share
Book value per share$151.37+0.7%$150.29-2.2%$153.65-1.3%$155.67+1.0%
Valuation
Market capitalization$467.91B+4.9%$446.21B+2.9%$433.66B-8.0%$471.37B-23.6%
Enterprise value$577.41B+4.5%$552.68B+4.4%$529.62B-6.2%$564.9B-20.8%
Price / earnings99.5×-5.0×104.5×-7.4×111.9×+1.8×110.1×-25.7×
Price / sales13.3×-0.2×13.5×0.0×13.5×-1.7×15.2×-4.2×
Price / book9.6×+0.4×9.2×+0.7×8.5×-0.6×9.1×-2.8×
EV / EBITDA62.8×-4.6×67.3×+2.5×64.8×-2.2×67×-22.3×
EV / sales16.4×-0.3×16.7×+0.2×16.5×-1.7×18.2×-4.3×
Free cash flow yield18.4%-0.7pp19.1%+1.9pp17.2%+0.9pp16.3%+1.1pp
Earnings yield16.2%+0.9pp15.4%+0.9pp14.5%-0.2pp14.7%+2.5pp
Dividend yield12.5%-0.5pp13%-0.6pp13.6%+1.6pp12%+3.4pp
PEG ratio14.2×-15.2×29.4×

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are Medtronic's profit margins?
Medtronic (MDT) runs a 64.9% gross margin and a 17.0% operating margin, with a 13.0% net margin.
Where do Medtronic's ratios come from?
Every ratio is computed from Medtronic's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.